Connection
Lisa Brenner to Fibroblast Growth Factor 2
This is a "connection" page, showing publications Lisa Brenner has written about Fibroblast Growth Factor 2.
|
|
Connection Strength |
|
 |
|
 |
|
0.025 |
|
|
|
-
Lustberg MB, Pant S, Ruppert AS, Shen T, Wei Y, Chen L, Brenner L, Shiels D, Jensen RR, Berger M, Mrozek E, Ramaswamy B, Grever M, Au JL, Wientjes MG, Shapiro CL. Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes. Cancer Chemother Pharmacol. 2012 Jul; 70(1):49-56.
Score: 0.025